Opinion
Video
Patient Communication and Treatment Adherence in NMIBC
Author(s):
Experts discuss the potential impact of FDA-approved novel delivery systems on patients’ quality of life and treatment adherence in the management of non–muscle-invasive bladder cancer (NMIBC).
Video Player is loading.
Video content above is prompted by the following:
- If they are FDA approved, what impact are the novel delivery systems likely to have on patients’ quality of life? Treatment adherence?
Related Videos
Clinical Benefits of BPH Treatments
BPH Management: Patient Outcome Evolution
Final Thoughts and Clinical Trials in NMIBC
Uptake of New Treatments in Urology Practice
Resective Surgery and Minimally Invasive Procedures For BPH
Operationalizing TAR-200 and Other Delivery Systems in Practice
Unmet Needs in NMIBC
Checkpoint Inhibitors for Treatment of NMIBC
Communication of Treatment Options for High-Risk NMIBC
Subgroup Analyses and Clinical Insights in Metastatic Hormone-Sensitive Prostate Cancer Treatment
Related Content
